NewsBenzingaTempus AI Extends Recursion Data Deal Through 2029, Replacing Potential $84M Fees With $42M In Committed Payments, In Addition To Licensing Recursion’s RNA Foundation Model "TxFM" Under A Separate License Agreement Tempus AI Extends Recursion Data Deal Through 2029, Replacing Potential $84M Fees With $42M In Committed Payments, In Addition To Licensing Recursion’s RNA Foundation Model "TxFM" Under A Separate License Agreement Benzinga 2026.09.21 13:20 (GMT+0) Open on Benzinga Other news Home BancShares Q3 Adj. EPS $0.65 Beats $0.64 Estimate, Sales $288.400M Miss $294.267M Estimate $100 Invested In Texas Instruments 15 Years Ago Would Be Worth This Much Today DexCom's CONNECT Study Published In The New England Journal Of Medicine; Findings Support The Role Of CGM Earlier In Type 2 Diabetes Care For All People, Including Those Over The Age Of 65 SKYX Platforms Files Prospectus Related To The Offer And Resale Of Up To 25,250,000 Shares Of Common Stock By The Selling Securityholders MSC Industrial Direct Company Raises Its Quarterly Cash Dividend From $0.87 To $0.89 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
DexCom's CONNECT Study Published In The New England Journal Of Medicine; Findings Support The Role Of CGM Earlier In Type 2 Diabetes Care For All People, Including Those Over The Age Of 65
SKYX Platforms Files Prospectus Related To The Offer And Resale Of Up To 25,250,000 Shares Of Common Stock By The Selling Securityholders
